References

ppharm

Педиатрическая фармакология

Pediatric pharmacology

1727-57762500-3089

Издательство «ПедиатрЪ»

10.15690/pf.v17i4.2168

ppharm-1878

Research Article

ПО МАТЕРИАЛАМ EPA/UNEPSA И IPA

Materials (WHO, EPA/UNESPA, IPA)

Эпидемиология, характеристика и влияние COVID-19 на детей, подростков и беременных женщин

Epidemiology, Spectrum, and Impact of COVID-19 on Children, Adolescents, and Pregnant Women

Ирфан

О.

Irfan

Omar

Танг

К.

Tang

Kun

Торонто, Канада;

Пекин, Китай

Toronto, Canada;

Beijing, China

Арии

М.

Arii

Maya

Нью-Йорк

Бхутта

З. А.

Bhutta

Zulfiqar A.

Торонто, Канада;

Южно-центральная Азия, Восточная Африка и Великобритания

Toronto, Canada;

South-Central Asia, East Africa & UK

Центр Всемирной Охраны Здоровья Детей, Детская больницаКанадаCentre for Global Child Health, The Hospital for Sick ChildrenCanada

Центр Всемирной Охраны Здоровья Детей, Детская больница; Школа общественного здравоохранения Ванке, Университет ЦинхуаКанадаCentre for Global Child Health, The Hospital for Sick Children; Vanke School of Public Health, Tsinghua UniversityCanada

UNICEFСоединённые Штаты АмерикиUNICEFUnited States

Центр Всемирной Охраны Здоровья Детей, Детская больница; Институт Всемирной Охраны Здоровья и Развития, Университет Ага-ханаКанадаCentre for Global Child Health, The Hospital for Sick Children; Institute for Global Health & Development, the Aga Khan UniversityCanada

2020

10092020

174352359

2020

Ирфан О., Танг К., Арии М., Бхутта З.А.

Irfan O., Tang K., Arii M., Bhutta Z.A.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.pedpharma.ru/jour/article/view/1878

Эта статья была ранее опубликована на английском языке. Irfan O, Tang K, Arii M, Bhutta ZA. Epidemiology, Spectrum, and Impact of COVID-19 on Children, Adolescents, and Pregnant Women. Joint IPA-UNICEF COVID-19 Information Brief, June 29, 2020. Avalaible online: https://www.unicef.org/bulgaria/sites/unicef.org.bulgaria/files/2020-07/UNICEF-IPA_COVID_brief_WEB_29June_ENG.pdf. Accessed on: September 7, 2020.

References1

WHO. Coronavirus disease (COVID-19) outbreak situation. Avalaible online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed on: September 7, 2020.

World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard 2020. Available online: https://covid19.who.int/. Accessed on: September 7, 2020.

World Health Organization. Coronavirus disease (COVID-19) Situation Report - 162 2020 [cited 2020 29 June]. Available online: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200629-covid-19-sitrep-161.pdf?sfvrsn=74fde64e_2. Accessed on: September 7, 2020.

Dong Y, Mo X, Hu Y, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020;145 (6):e20200702. doi: 10.1542/peds.2020-0702.

CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children — United States, February 12 – April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):422–426. doi: 10.15585/mmwr.mm6914e4.

European Centre for Disease Prevention and Control. COVID-19 cases 2020. Available online: https://qap.ecdc.europa.eu/public/extensions/COVID-19/COVID-19.html. Accessed on: September 7, 2020.

Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088–1095. doi: 10.1111/apa.15270.

World Health Organization. Key Messages and Actions for COVID-19 Prevention and Control in Schools 2020 [cited 2020 25 June]. Available online: https://www.who.int/docs/default-source/coronaviruse/key-messages-and-actions-for-covid-19-prevention-and-control-in-schools-march-2020.pdf?sfvrsn=baf81d52_4. Accessed on: September 7, 2020.

Irfan O, Tang K, Lassi Z, Bhutta Z. Systematic review of clinical characteristics, treatment modalities and outcomes of SARS-Cov-2 infection in newborns, infants, children and adolescents as per the infection severity. Systematic Review in progress. PROSPERO. International prospective register of systematic reviews. 2020;CRD42020183134. Available online: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020183134.2020. Accessed on: September 7, 2020.

Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020;382(17):1663-1665. doi: 10.1056/NEJMc2005073.

Posfay-Barbe KM, Wagner N, Gauthey M, et al. COVID-19 in Children and the Dynamics of Infection in Families. Pediatrics. 2020;146(2):e20201576. doi: 10.1542/peds.2020-1576.

National Centre for Immunisation Research and Surveillance (NCIRS). COVID-19 in schools — the experience in NSW. 2020. Available online: http://ncirs.org.au/sites/default/files/2020-04/NCIRS%20NSW%20Schools%20COVID_Summary_FINAL%20public_26%20April%202020.pdf. Accessed on: September 7, 2020.

Danis K, Epaulard O, Bénet T, et al. Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020. Clin Infect Dis. 2020;71(15):825–832. doi: 10.1093/cid/ciaa424.

Davies NG, Klepac P, Liu Y, et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med. 2020;26(8):1205–1211. doi: 10.1038/s41591-020-0962-9. 2020.

Monteleone PA, Nakano M, Lazar V, et al. A review of initial data on pregnancy during the COVID-19 outbreak: implications for assisted reproductive treatments. JBRA Assist Reprod. 2020;24(2):219. doi: 10.5935/1518-0557.20200030.

Elshafeey F, Magdi R, Hindi N, et al. A systematic scoping review of COVID-19 during pregnancy and childbirth. Int J Gynaecol Obstet. 2020;150(1):47–52. doi: 10.1002/ijgo.13182.

Lassi Z, Ali A, Das J, et al. A systematic analysis of pregnant women with COVID-19: clinical presentation, and pregnancy and neonatal outcomes as per COVID-19 severity. Systematic Review in progress. PROSPERO. International prospective register of systematic reviews. 2020;CRD42020182048 Available online: https://www.crd.york.ac.uk/prospero/display_record. php?ID=CRD42020182048. Accessed on: September 7, 2020.

Yan J, Guo J, Fan C, et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases. Am J Obstet Gynecol. 2020;223(1):111.e1–111.e14. doi: 10.1016/j.ajog.2020.04.014.

Chen L, Li Q, Zheng D, et al. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China. N Engl J Med. 2020;382(25):e100. doi: 10.1056/NEJMc2009226. 2020.

Juan J, Gil MM, Rong Z, et al. Effects of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcomes: a systematic review. Ultrasound Obstet Gynecol. 2020;56(1):15–27. doi: 10.1002/uog.22088.

Penfield C BS, Limaye M et al. . Detection of severe acute respiratory syndromecoronavirus 2 in placental and fetal membranesamples. Am J Obstet Gynecol MFM. 2020;2(3):100133. doi: 10.1016/j.ajogmf.2020.100133.

Patanè L, Morotti D, Giunta MR, et al. Vertical transmission of coronavirus disease 2019: severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019 — positive mothers and neonates at birth. Am J Obstet Gynecol MFM. 2020;2(3):100145. doi: 10.1016/j.ajogmf.2020.100145.

Dumpa V, Kamity R, Vinci AN, et al. Neonatal Coronavirus 2019 (COVID-19) Infection: A Case Report and Review of Literature. Cureus. 2020;12(5):e8165. doi: 10.7759/cureus.8165.

Groß R, Steinhart K, Kirchhoff F, Münch J. Detection of SARS-CoV-2 in human breastmilk. Lancet. 2020;395(10239):1757-1758. doi: 10.1016/ S0140-6736(20)31181-8.

World Health Organization. Clinical management of COVID-19: Interim guidance, May 27, 2020. Available online: https://www.who.int/publications/i/item/clinical-management-of-covid-19. Accessed on: September 7, 2020.

Jones TC, Mühlemann B, Veith T, et al. An analysis of SARS-CoV-2 viral load by patient age. German Research network Zoonotic Infectious Diseases website. 2020. doi: 10.1101/2020.06.08.20125484.

Lu Y, Li Y, Deng W, et al. Symptomatic infection is associated with prolonged duration of viral shedding in mild coronavirus disease 2019: a retrospective study of 110 children in Wuhan. Pediatr Infect Dis J. 2020;39(7):e95–e99. doi: 10.1097/INF.0000000000002729.

Parri N, Lenge M, Buonsenso D. Children with Covid-19 in Pediatric Emergency Departments in Italy. N Engl J Med. 2020; 383(2):187–190. doi:10.1056/NEJMc2007617.

de Souza TH, Nadal JA, Nogueira RJ, et al. Clinical Manifestations of Children with COVID-19: a Systematic Review. Pediatr Pulmonol. 2020;55(8):1892–1899. doi: 10.1002/ppul.24885.

Chen A, Huang J, Liao Y, et al. Differences in clinical and imaging presentation of pediatric patients with COVID-19 in comparison with adults. Radiol Cardiothorac Imag. 2020;2(2):e200117. doi: 10.1148/ryct.2020200117.

Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatr. 2020 May 11. Online ahead of print. doi:10.1001/jamapediatrics.2020.1948.

Weiss SL, Peters MJ, Alhazzani W, et al. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-associated Organ Dysfunction in Children. Intensive Care Med. 2020;46(Suppl 1):10–67. doi: 10.1007/s00134-019-05878-6.

Ledford H. Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature. 2020;582(7813):469. doi: 10.1038/d41586-020-01824-5.

WHO. News release: WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients. 2020. Available online: https://www.who.int/news-room/detail/16-06-2020-who-welcomes-preliminary-results-about-dexametha-sone-use-in-treating-critically-ill-covid-19-patients. Accessed on: September 7, 2020.

Riphagen S, Gomez X, Gonzalez-Martinez C, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607–1608. doi: 10.1016/S0140-6736(20)31094-1.

European Centre for Disease Prevention and Control. Paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children — 15 May 2020. ECDC: Stockholm; 2020.

CDC U. Information for Healthcare Providers about Multisystem Inflammatory Syndrome in Children (MIS-C). Available online: https://www.cdc.gov/mis-c/hcp. Accessed on: September 7, 2020.

Rauf A, Vijayan A, John ST, et al. Multisystem Inflammatory Syndrome with Features of Atypical Kawasaki Disease during COVID-19 Pandemic. Indian J Pediatr. 2020;87(9):745–747. doi: 10.1007/s12098-020-03357-1.

Balasubramanian S, NagendranT M, Ramachandran B, Ramanan AV. Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully with Intravenous Immunoglobulin and Tocilizumab. Indian Pediatr. 2020;57(7):681–683. doi: 10.1007/s13312-020-1901-z.

Whittaker E, Bamford A, Kenny J, et al. Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA. 2020 Jun 8;e2010369. Online ahead of print. doi: 10.1001/jama.2020.1036.

CDC U. Severe outcomes among patients with COVID-19 — United States, Feb 12 – March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(12):343–346. doi: 10.15585/mmwr.mm6912e2.

WHO. Multisystem inflammatory syndrome in children and adolescents with COVID-19: Scientific brief, May 15, 2020. Available online: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. Accessed on: September 7, 2020.

Health RCoPaC. Guidance: paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS). 2020. Available online: https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-%20inflammato-ry%20syndrome-20200501.pdf. Accessed on: September 7, 2020.

WHO. Global COVID-19 clinical platform: case report form for suspected cases of multisystem inflammatory syndrome (MIS) in children and adolescents temporally related to COVID-19. May 18, 2020. Available online: https://apps.who.int/iris/bitstream/handle/10665/332121/WHO-2019-nCoV-MIS_Children_CRF-2020.1-eng.pdf. Accessed on: September 7, 2020.

UN. Policy Brief: The Impact of COVID-19 on children. April 15, 2020. Available online: https://unsdg.un.org/sites/default/files/2020-04/160420_Covid_Children_Policy_Brief.pdf. Accessed on: September 7, 2020.

UNICEF. COVID-19: Number of children living in household poverty to soar by up to 86 million by end of year. May 27, 2020. Available online: https://www.unicef.org/press-releases/covid-19-number-children-living-household-poverty-soar-86-million-end-year. Accessed on: September 7, 2020.

UNESCO. Education: From disruption to recovery. Available online: https://en.unesco.org/covid19/educationresponse. Accessed on: September 7, 2020.

Programme WF. 2020 – Global Report on Food Crises. April 20, 2020. Available online: https://docs.wfp.org/api/documents/WFP-0000114546/download/?_ga=2.26030910.203248295.1599480598-439563952.1599480598.pdf. Accessed on: September 7, 2020.

Viner RM, Russell SJ, Croker H, et al. School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review. Lancet Child Adolesc Health. 2020;4(5):397–404. doi: 10.1016/S2352-4642(20)30095-X.

Roberton T, Carter ED, Chou VB, et al. Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020;8(7):e901–e908. doi: 10.1016/S2214-109X(20)30229-1.

WHO. At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupts routine vaccination efforts, warn Gavi, WHO and UNICEF: News release, May 22, 2020. Available online: https://www.who.int/news-room/detail/22-05-2020-at-least-80-million-children-under-one-at-risk-of-diseases-such-as-diphtheria-measles-and-polio-as-covid-19-disrupts-routine-vaccination-efforts-warn-gavi-who-and-unicef. Accessed on: September 7, 2020.

UNICEF. More than 117 million children at risk of missing out on measles vaccines, as COVID-19 surges: Statement by the Measles & Rubella Initiative: American Red Cross, U.S. CDC, UNICEF, UN Foundation and WHO, April 13, 2020. Available online: https://www.unicef.org/press-releases/more-117-million-children-risk-missing-out-measles-vaccines-covid-19-surges. Accessed on: September 7, 2020.

Klein JD, Koletzko B, El-Shabrawi MH, et al. Promoting and supporting children’s health and health-care during COVID-19 — International Paediatric Association Position Statement. Arch Dis Child. 2020;105(7):620–624. doi: 10.1136/ archdischild-2020-319370.

WHO. Considerations for school-related public health mea-sures in the context of COVID-19: Annex to Considerations in adjusting public health and social measures in the context of COVID-19, May 10, 2020. Available online: https://www.who.int/publications/i/item/considerations-for-school-related-public-health-measures-in-the-context-of-covid-19. Accessed on: September 7, 2020.

UNICEF, WHO, IFRC. Interim Guidance for COVID-19 Prevention and Control in Schools. Marth, 2020. Available online: https://www.unicef.org/media/66216/file/Key%20Messages%20and%20Actions%20for%20COVID-19%20Prevention%20and%20Control%20in%20Schools_March%202020.pdf. Accessed on: September 7, 2020.

UNICEF. Framework for Reopening Schools: From UNESCO, UNICEF, the World Bank, the World Food Programme and UNHCR, June, 2020. Available online: https://www.unicef.org/media/71366/file/Framework-for-reopening-schools-2020.pdf. Accessed on: September 7, 2020.

The authors declare that there are no conflicts of interest present.